Related Experiment Video
Updated: May 4, 2026
07:34
FISH for Pre-implantation Genetic Diagnosis
Published on: February 23, 2011
40.0K
[Prenatal diagnostics: current medical aspects].
1Zentrum für Pränataldiagnostik und Humangenetik Kudamm-199, Kurfürstendamm 199, 10719, Berlin, Deutschland, stumm@kudamm-199.de.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz
|December 17, 2013
Summary
Advancements in prenatal diagnosis, including ultrasound and noninvasive tests using cell-free fetal DNA, have significantly reduced invasive procedures. This trend is expected to further decrease procedure-related abortions.
Area of Science:
- Medical Diagnostics
- Genetics
- Obstetrics
Context:
- Rapid advancements in prenatal diagnostic technologies over recent years.
- Significant improvements in sonographic examinations and first-trimester screening protocols.
- Emergence of noninvasive prenatal testing (NIPT) utilizing cell-free fetal DNA.
Purpose:
- To analyze the impact of technological advancements on invasive prenatal diagnostic procedures.
- To project future trends in prenatal diagnostics and their implications.
- To highlight the declining role of invasive procedures in prenatal care.
Summary:
- Invasive prenatal diagnostic procedures have decreased by over 50% due to enhanced sonography and first-trimester screening.
- The introduction of noninvasive prenatal diagnostic tests (NIPT) using cell-free fetal DNA from maternal blood is further accelerating this trend.
- Consequently, the incidence of procedure-related abortions is anticipated to decline as invasive methods become less frequent.
Impact:
- Reduced need for invasive prenatal diagnostic procedures.
- Decreased risk of complications and abortions associated with prenatal testing.
- Shift towards safer, noninvasive methods in prenatal care, improving patient outcomes.
Related Concept Videos
01:07Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
01:28Development of the Oral Microbiota
65
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
65
01:29Pharmacogenetics and Pharmacogenomics: Overview
253
Pharmacogenetics and pharmacogenomics examine how genetic factors influence an individual's response to drugs. While pharmacogenetics focuses on the impact of specific genetic variants on drug effects, pharmacogenomics takes a broader approach, studying how genetic variation across populations contributes to differences in drug responses. These fields aim to explain why individuals may experience varying levels of efficacy or adverse reactions to the same medication.Variability in drug...
253
02:59Animal Mitochondrial Genetics
7.8K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.8K